Female Urogenital Diseases

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Lumenis
LumenisAustralia - Chatswood
1 program
C02 microablative laserN/A1 trial
Active Trials
NCT05585476Not Yet Recruiting180Est. Sep 2026

Trial Timeline

Clinical trial activity over time

2025
2026
LumenisC02 microablative laser

Clinical Trials (1)

Total enrollment: 180 patients across 1 trials

NCT05585476LumenisC02 microablative laser

A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients.

Start: Oct 2025Est. completion: Sep 2026180 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space